{"id":"https://openalex.org/W4379340541","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.9563","title":"Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma.","display_name":"Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379340541","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.9563"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.9563","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.9563","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.9563","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026672076","display_name":"Geoffrey Thomas Gibney","orcid":"https://orcid.org/0000-0002-5401-8498","observed_orcids":["https://orcid.org/0000-0002-5401-8498"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Thomas Gibney","raw_affiliation_strings":["Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033513950","display_name":"Andrew L. Pecora","orcid":"https://orcid.org/0000-0002-8368-0632","observed_orcids":["https://orcid.org/0000-0002-8368-0632"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew L Pecora","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042621368","display_name":"Suthee Rapisuwon","orcid":"https://orcid.org/0000-0002-1389-925X","observed_orcids":["https://orcid.org/0000-0002-1389-925X"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suthee Rapisuwon","raw_affiliation_strings":["Washington Cancer Institute/Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington Cancer Institute/Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100350895","display_name":"Kevin Chen","orcid":"https://orcid.org/0000-0002-3851-6016","observed_orcids":["https://orcid.org/0000-0002-3851-6016"]},"institutions":[{"id":"https://openalex.org/I2799338006","display_name":"MedStar Franklin Square Medical Center","ror":"https://ror.org/01509dj67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799338006"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Chen","raw_affiliation_strings":["Medstar Franklin Square Medical Center, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medstar Franklin Square Medical Center, Baltimore, MD","institution_ids":["https://openalex.org/I2799338006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061140126","display_name":"Kellie Gardner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kellie Gardner","raw_affiliation_strings":["Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110985746","display_name":"Gayle Cramer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gayle Cramer","raw_affiliation_strings":["Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068068500","display_name":"Danielle Blair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Blair","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076894327","display_name":"Amy Avergas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799338006","display_name":"MedStar Franklin Square Medical Center","ror":"https://ror.org/01509dj67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799338006"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Avergas","raw_affiliation_strings":["Medstar Franklin Square Medical Center, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medstar Franklin Square Medical Center, Baltimore, MD","institution_ids":["https://openalex.org/I2799338006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055925131","display_name":"Nicole Swanson","orcid":"https://orcid.org/0009-0007-1851-3938","observed_orcids":["https://orcid.org/0009-0007-1851-3938"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Swanson","raw_affiliation_strings":["Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown - Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090941234","display_name":"Jaeil Ahn","orcid":"https://orcid.org/0000-0001-7998-4759","observed_orcids":["https://orcid.org/0000-0001-7998-4759"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaeil Ahn","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"9563","last_page":"9563"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9079999923706055},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.8539999723434448},{"id":"https://openalex.org/keywords/c-met-inhibition","display_name":"c-Met inhibition","score":0.6779999732971191},{"id":"https://openalex.org/keywords/vegfr-2-inhibition","display_name":"VEGFR-2 inhibition","score":0.9850000143051147},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.625},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9599999785423279},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8849999904632568},{"id":"https://openalex.org/keywords/simon-2-stage-design","display_name":"Simon 2-stage design","score":0.6200000047683716},{"id":"https://openalex.org/keywords/interim-analysis","display_name":"interim analysis","score":0.7149999737739563},{"id":"https://openalex.org/keywords/braf-v600-mutation","display_name":"BRAF V600 mutation","score":0.781000018119812},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9185134172439575},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8620884418487549},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6782732605934143},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6636902093887329},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6181060075759888},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6062396168708801},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6015155911445618},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.5389057397842407},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.533807098865509},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.48780515789985657},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.47292429208755493},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4167625606060028},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4110109210014343},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3529033660888672},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32789841294288635},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.24981042742729187},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2070704698562622},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.11956420540809631}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.9563","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.9563","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.9563","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312140","display_name":"Exelixis","ror":"https://ror.org/01e3jga91"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4255570399","https://openalex.org/W4387811041","https://openalex.org/W4379281208","https://openalex.org/W2947247183","https://openalex.org/W2345990767","https://openalex.org/W2891505315","https://openalex.org/W2804569878","https://openalex.org/W2890791585","https://openalex.org/W2922063178","https://openalex.org/W4399449829"],"abstract_inverted_index":{"9563":[0],"Background:":[1],"Nivolumab/ipilimumab":[2],"(Nivo/Ipi)":[3],"is":[4],"a":[5,91,108,214,361],"standard":[6],"therapy":[7],"in":[8,45,82,97,172,213,356,399],"patients":[9,100,315],"with":[10,38,159,253,258,263,297,395,433],"unresectable":[11,160],"stage":[12,161,217,249,414],"III/IV":[13,162],"melanoma,":[14],"demonstrating":[15],"an":[16],"objective":[17],"response":[18],"rate":[19,29,276,324],"(ORR)":[20],"of":[21,30,93,113,227,415],"58%":[22],"and":[23,47,56,65,78,118,122,164,199,261,302,340,371,382],"12-month":[24,189,222,274,322],"progression":[25,153,223,342],"free":[26],"survival":[27,197],"(PFS)":[28],"49%":[31],"[Wolchok":[32],"J,":[33],"NEJM":[34],"2017].":[35],"c-MET/VEGFR2":[36],"inhibition":[37],"cabozantinib":[39],"(Cabo)":[40],"has":[41],"modest":[42],"clinical":[43,76],"activity":[44,77,392],"melanoma":[46,99,163,184,401],"can":[48],"augment":[49],"antitumor":[50],"immunity":[51],"by":[52,134],"increasing":[53,66],"CD8+":[54],"Tcell":[55,63],"macrophage":[57],"tumor":[58,67],"infiltration,":[59],"decreasing":[60],"intratumoral":[61],"regulatory":[62],"levels,":[64],"cell":[68],"MHC":[69],"antigen":[70],"presentation.":[71],"Nivo/Ipi":[72,94,396],"plus":[73,95,138,397],"Cabo":[74,96,123,139,398],"showed":[75],"acceptable":[79],"toxicity":[80],"profile":[81,418],"GU":[83],"malignancies":[84],"[Apolo":[85],"AB,":[86],"JCO":[87],"2020].":[88],"We":[89,106],"performed":[90],"study":[92,112,348],"advanced":[98,400],"aimed":[101],"at":[102,318],"improving":[103],"efficacy.":[104],"Methods:":[105],"conducted":[107],"multicenter":[109],"phase":[110],"II":[111],"induction":[114],"Nivo":[115,135],"3mg/kg":[116],"IV":[117,121,137,250],"Ipi":[119],"1mg/kg":[120],"40mg":[124,140],"PO":[125,141],"daily":[126,142],"every":[127,143],"3":[128,282,344],"weeks":[129,145],"for":[130,146,331],"4":[131,144,300],"cycles,":[132],"followed":[133],"480mg":[136],"up":[147,270],"to":[148,409,411,421,428],"2":[149,216,298,377],"years,":[150,247],"until":[151],"disease":[152,341],"or":[154,168,309],"unacceptable":[155],"toxicity/patient":[156],"withdrawal.":[157],"Patients":[158],"no":[165],"prior":[166,422],"anti-PD-1":[167],"CTLA-4":[169],"exposure":[170],"(unless":[171],"adjuvant":[173],"setting":[174],">":[175],"6":[176,262],"months":[177],"since":[178],"last":[179,319],"dose)":[180],"were":[181,211,231,316,354,367,379],"included.":[182],"Uveal":[183],"excluded.":[185],"Primary":[186],"endpoint":[187],"was":[188,205,271,277,292,325,393,419],"PFS":[190,275,285,288],"rate.":[191],"Secondary":[192],"endpoints":[193],"included":[194,334],"ORR,":[195],"overall":[196],"(OS),":[198],"adverse":[200],"events":[201],"(AEs).":[202],"Interim":[203],"analysis":[204],"preplanned":[206],"after":[207],"first":[208],"14":[209,229],"subjects":[210,221,230,283,345],"evaluated":[212],"Simon":[215],"design":[218],"(goal":[219],">8":[220],"free).":[224],"Results:":[225],"As":[226],"1/2023,":[228],"enrolled":[232],"across":[233],"three":[234],"cancer":[235],"centers":[236],"within":[237],"the":[238,406,412],"Georgetown-Lombardi":[239],"Comprehensive":[240],"Cancer":[241],"Center":[242],"Consortium.":[243],"Median":[244,268],"age":[245],"66.5":[246],"all":[248],"disease,":[251],"10":[252],"cutaneous":[254,307],"primary":[255,312],"site,":[256],"5":[257],"elevated":[259,368],"LDH,":[260],"BRAF":[264],"V600":[265],"mutant":[266],"tumor.":[267],"follow":[269,320],"10.6":[272],"mos.":[273,290],"30%":[278],"(3/10":[279],"evaluable":[280,295,328],"subjects);":[281],"pending":[284],"evaluation;":[286],"median":[287],"10.3":[289],"ORR":[291],"46%":[293],"(6/13":[294],"subjects)":[296],"CR,":[299],"PR,":[301],"1":[303],"SD.":[304],"Responders":[305],"had":[306],"(5)":[308],"unknown":[310],"(1)":[311],"sites.":[313],"9":[314,359],"alive":[317],"up.":[321],"OS":[323],"67%":[326],"(6/9":[327],"subjects).":[329],"Reasons":[330],"treatment":[332,386],"discontinuation":[333],"AEs":[335,352],"(4),":[336],"patient":[337,430],"withdrawal":[338],"(1),":[339],"(6).":[343],"remain":[346],"on":[347],"drug(s).":[349],"Treatment":[350],"related":[351,387],"(TRAEs)":[353],"observed":[355,394],"13":[357],"subjects;":[358],"experienced":[360],"grade":[362,376],"3-4":[363],"TRAE":[364,417],"(most":[365],"frequent":[366,375],"AST/ALT":[369],"29%":[370],"hypokalemia":[372],"14%).":[373],"Most":[374],"TRAEs":[378],"diarrhea":[380],"(35%)":[381],"palmar-planter-erythrodysesthesia":[383],"(29%).":[384],"No":[385],"deaths":[388],"occurred.":[389],"Conclusions:":[390],"Clinical":[391,439],"but":[402],"did":[403],"not":[404],"meet":[405],"predefined":[407],"threshold":[408],"advance":[410],"second":[413],"enrollment.":[416],"similar":[420],"reports.":[423],"Biomarker":[424],"analyses":[425],"are":[426],"planned":[427],"identify":[429],"profiles":[431],"associated":[432],"particular":[434],"benefit":[435],"from":[436],"this":[437],"regimen.":[438],"trial":[440],"information:":[441],"NCT04091750":[442],".":[443]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-06-05T00:00:00"}